Clinical Trial Update: A Phase II Study of UCN-01 in Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase II trial of UCN-01 in metastatic melanoma was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• UCN-01 (7-hydroxystaurosporine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2015-03-02